✓ Independent editorial reviews · Educational only — not medical advice

GLP-1 Telehealth Articles

Released: · Last reviewed:

New October reports first, then evidence guides.

What is here

As of October 15, 2026, this library holds 13 articles on GLP-1 telehealth: two new October pieces on patient screening and on Sunlight versus MEDVi, plus trial-based guides to tirzepatide and semaglutide dosing, side effects, weight-loss evidence and what happens after stopping.

Clinical articles summarize trials of the FDA-approved products; compounded versions were not studied in them.

CNN Report on GLP-1s and Anorexia: How to Check a Program's Screening

New, October 2026

Sunlight vs MEDVi: What Each GLP-1 Program Costs After Month One

New, October 2026

Expected Weight Loss on Tirzepatide

What weight loss to realistically expect on tirzepatide. SURMOUNT-1 trial results by dose, weekly weight loss patterns, and how to maximize results.

GLP-1 Side Effects: What the Evidence Shows and How They're Managed

The most common GLP-1 side effects reported in the STEP and SURMOUNT trials, who should be cautious, how slow titration and clinician oversight reduce them.

How Much Weight Loss on GLP-1s? The 2026 Trial Evidence

How much weight people lost on GLP-1s in trials: STEP, SURMOUNT and SURMOUNT-5 head-to-head (20.2% vs 13.7%), plus oral-drug data, in plain language.

How Tirzepatide Works

How tirzepatide works: it activates GIP and GLP-1 receptors to cut appetite, slow stomach emptying and improve insulin response. The biology in plain English.

How to Take Tirzepatide

How to take tirzepatide: the 2.5 mg starting dose, 4-week steps to 5–15 mg, injection sites, missed doses and storage, per the FDA prescribing information.

Oral GLP-1 Pills in 2025: Orforglipron and Oral Semaglutide Evidence

What 2025 trials showed about oral GLP-1 options — orforglipron (ATTAIN) and high-dose oral semaglutide (OASIS-4) — and what they mean for patients.

Semaglutide Beyond Weight Loss: SELECT and FLOW Evidence

What the SELECT and FLOW trials showed about semaglutide beyond weight loss: a 20% cut in major heart events and kidney protection, in plain language.

SURMOUNT-5: Tirzepatide vs Semaglutide Head-to-Head (2025 Evidence)

What the 2025 SURMOUNT-5 head-to-head trial showed about tirzepatide versus semaglutide for weight loss, and what it means for telehealth patients.

Tirzepatide Side Effects

Complete guide to tirzepatide side effects. Common GI effects, serious risks, FDA boxed warning, and how to manage adverse events through dose titration.

Tirzepatide vs Semaglutide

Side-by-side comparison of tirzepatide and semaglutide for weight loss in 2026. Mechanism, efficacy, cost, side effects, and which is right for you.

Weight Regain After Stopping GLP-1s: What STEP-4 Found

What the STEP 4 trial found about weight regain after people stopped semaglutide, and what that means for planning the long-term cost of GLP-1 care.

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.